ProQR to Present its Axiomer® RNA Editing Technology at the Oligonucleotide and Peptide Therapeutics Conference (TIDES Europe) 2022 Press release LEIDEN, Netherlands & CAMBRIDGE, Mass., Nov. 14, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. November 14, 2022
Axiomer Technology - Therapeutic oligonucleotides for directing site-specific A-to-I editing by endogenous ADAR enzymes Presentation … EU 2018 by Antti Aalto - ProQR Therapeutics Presented at TIDES Europe 2018 by Antti Aalto - ProQR Therapeutics … November 06, 2018
Progress on Development of RNA Base Editing Technologies for Precision Medicines Presentation Progress on Development of RNA Base Editing Technologies for Precision Medicines, including Axiomer® platform presented at TIDES EU by Gerard Platenburg - ProQR Therapeutics November 18, 2022
ProQR Announces Third Quarter 2022 Operating and Financial Results Press release … have made advancing Axiomer, including our presentation at TIDES Europe later this month, disclosure of our pipeline … November 09, 2022
